Trial Profile
Metabolism and Pharmacokinetics of [14C] BIBW 2992 MA2 After Administration of Single Doses of 15 mg [14C] BIBW 2992 MA2 Oral Solution in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 20 Oct 2015
Price :
$35
*
At a glance
- Drugs Afatinib (Primary)
- Indications Breast cancer; Colorectal cancer; Glioblastoma; Glioma; Head and neck cancer; Non-small cell lung cancer; Prostate cancer; Solid tumours
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim
- 30 Jun 2014 New trial record